US Life Science Patents to New Zealand assignees, 2014
US Life Science Patents to New Zealand assignees, 2014
The US Patent Office issues new patents every Tuesday. New Zealand assignees generally get one or two healthcare and biotech-related patents a month. Here are the 15 US patents relevant to New Zealand's Life Sciences sector that issued in 2014.
US Patent 8,889,636
|
Description: This patent antifungal compounds extracted from Epicoccum nigrum.
|
US Patent 8,877,465
|
Title: Production of ultrapure EPA and polar lipids from largely heterotrophic culture
Issued: 4 November 2014 Assignee: Photonz |
Description: This patent covers a method for producing EPA from micro-organisms such as the diatom Nitzschia laevis.
|
US Patent 8,835,397
|
Description: This patent covers an improved formulation of ivermectin.
|
US Patent 8,821,921
|
Title: Vitamin D3 for the transdermal treatment of pain and inflammation
Issued: 2 September 2014 Assignee: Anzamed International (Dr John Lyftogt) |
Description: This patent covers the use of vitamin D3 in treating neuropathic pain.
|
US Patent 8,809,301
|
Title: Surgical hydrogel
Issued: 19 August 2014 Assignee: Robinson Squidgel Ltd (33%), University of Otago (33%), Adelaide Research & Innovation (Australia 33%). |
Description: The patent covers a gel useful in reducing post-surgery sinus scarring, where the actives come from polymers found in squid and crab shell.
|
US Patent 8,791,117
|
Title: Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
Issued: 29 July 2014 Assignee: Neuren Pharmaceuticals (ASX: NEU) |
Description: This patent covers Neuren's modified tripeptide for the treatment of cognitive impairment.
|
US Patent 8,784,795
|
Title: Methods for determining personalized treatment compositions for prostate cancer and breast cancer
Issued: 22 July 2014 Assignee: Caldera Health |
Description: This patent covers the combination of an immune cell activating agent and an antigen display enhancing agent in order to determine the optimal therapy for each patient.
|
US Patent 8,758,781
|
Title: Tissue scaffolds derived from forestomach extracellular matrix
Issued: 24 June 2014 Assignee: Aroa Biosurgery |
Description: This patent covers extracellular matrix scaffolds derived from the forestomach of a ruminant, useful in tissue repair.
|
US Patent 8,709,448
|
Title: Anti-infective agents and uses thereof
Issued: 29 April 2014 Assignee: Innate Immunotherapeutics (ASX: IIL) |
Description: This patent covers the anti-infective applications of a muramyl dipeptide microparticle, which has immunostimulatory properties.
|
US Patent 8,703,699
|
Description: This patent covers a formulation of lactoferrin useful in treating bone-related disorders.
|
US Patent 8,679,527
|
Description: This patent covers the antimicrobial actives in honey from Leptospermum scoparium.
|
US Patent 8,669,084
|
Description: This patent covers peptide-lipid constructs that spontaneously incorporate into the membranes of cells.
|
US Patent 8,637,567
|
Title: Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid
Issued: 28 January 2014 Assignee: Neuren Pharmaceuticals (ASX: NEU) |
Description: This patent covers an analogue to the tripeptide glycyl-L-prolyl-L-glutamic acid useful for treating cognitive impairment.
|
US Patent 8,637,473
|
Description: This patent covers water soluble synthetic glycolipids incorporatable into a cell membrane.
|
US Patent 8,633,248
|
Title: Parenteral selenomethionine for production of selenium-rich foods
Issued: 21 January 2014 Assignee: AgResearch Ltd |
Description: This patent covers a selenomethionine formulation as a selenium dietary supplement.
|
Copyright © 2016 NDF Research